Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Phase IV Multicentre Study on the Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)

NCT00537914 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT00537914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Phase IV Multicentre Study on the Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)
Lead sponsor
Sandoz
Phase
Phase 4
Overall status
Completed
Start date
February 6, 2008
Completion date
March 25, 2022
Enrollment
278 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

small for gestational age